Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2008-01-30FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) from Viatris Specialty LLC, updating the product labe…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Effects of Parental Behavior on Child Anxiety Regulation [Phase 2]
Phase 2 clinical trial update reporting completion of a study on how parental behavior influences child anxiety regulation across Separation…
-
FDA approval · 2008-01-11FDA Approved: SERTRALINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for a sertraline generic product from Heritage Pharmaceuticals (Avet), authorizing changes to the ap…
-
FDA approval · 2008-01-08FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s sertraline hydrochloride generic under an Original Application. The approval provides a generic…
-
FDA approval · 2007-12-26FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for SERTRALINE HYDROCHLORIDE (generic) from Aurobindo Pharma Limited, updating the regulatory status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-12-14FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2007-10-25FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride, a generic sertraline product, under the ANDA.
-
FDA approval · 2007-10-16FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for fluvoxamine maleate filed by Chartwell RX, LLC.
-
FDA approval · 2007-09-20FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) filed by Viatris Specialty LLC.
-
FDA approval · 2007-08-01FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC. The action pertai…
-
FDA approval · 2007-07-25FDA Approved: PAROXETINE — Original Application (NorthStar Rx LLC)
FDA approves NorthStar Rx LLC's original ANDA for paroxetine hydrochloride (generic paroxetine).
-
FDA approval · 2007-07-12FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride submitted by Teva Pharmaceuticals USA, Inc. The approval updates t…
-
CLINICAL_TRIALS trial_result · 2007-06-14Clinical Trial Update: Treatment for Anxiety in Children [Phase 3]
A Phase 3 clinical trial evaluating a treatment for anxiety disorders in children has completed. The study covered obsessive-compulsive diso…
-
CLINICAL_TRIALS trial_result · 2007-06-08Clinical Trial Update: Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder [Phase 4]
A Phase 4 placebo-controlled trial of atomoxetine hydrochloride in adults with ADHD and comorbid social anxiety disorder has completed.
-
FDA approval · 2007-04-30FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals Inc)
FDA approved ScieGen Pharmaceuticals Inc.'s sertraline hydrochloride as a generic under an Original Abbreviated New Drug Application for the…
-
FDA approval · 2007-03-07FDA Approved: PAROXETINE — Original Application (Zydus Lifesciences Limited)
FDA approves Zydus Lifesciences Limited's original application for paroxetine hydrochloride tablets (generic paroxetine). This approval prov…
-
CLINICAL_TRIALS trial_result · 2007-02-13Clinical Trial Update: Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder [Phase 2]
This document reports Phase 2 results from a head-to-head trial comparing the investigational LY686017 with a marketed comparator in social …
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' sertraline hydrochloride as a generic drug via an Original ANDA approval.
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved an Original Application (ANDA) for sertraline hydrochloride from Quallent Pharmaceuticals Health LLC, a generic version of sert…
-
FDA approval · 2007-02-06FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
The FDA approved an original application for a generic sertraline hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2007-02-05FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for paroxetine hydrochloride as a generic product. Paroxetine is used to treat maj…
-
CLINICAL_TRIALS trial_result · 2007-01-29Clinical Trial Update: Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety [Phase 4]
Phase 4 trial of aripiprazole for schizophrenia with co-morbid social anxiety completed.
-
CLINICAL_TRIALS trial_result · 2006-12-19Clinical Trial Update: Quetiapine in Social Anxiety Disorder [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating quetiapine for social anxiety disorder, sponsored by Duke University, has been reported.
-
FDA approval · 2006-09-14FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2006-08-22FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.